WJK-15450-68727 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-18
Dose 1 — Pfizer-BioNTech
2021-01-08
Registered in v-safe
2021-01-08
Dose 2 — Pfizer-BioNTech
2021-01-08
Health check-in — day 0, dose 2
Feeling: Good · Site: Pain, Itching · Fatigue or tiredness

Adult check-in
2021-01-09
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Itching · Chills, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-01-13
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-02-21
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-07-10
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-01-08
Survey response — 12 months, dose 2
MedDRA: Breakthrough COVID-19, Cough, Headache, Heart rate increased, Unevaluable event — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Symptoms: Covid breakthrough infection. Symptoms included cough, headache, elevated heart rate. · Healthcare visit (other): I was only able to receive care after two weeks. My primary care was unable to see me and I could not go to my regular OB/gyn.

MedDRA releases: 2024-11 · check-in free text available
2022-01-08
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-01-10
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-18	Pfizer-BioNTech
2	2021-01-08	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2022-01-08	Unsuccessful

Free text

Release 10 — 12 months, dose 2

2022-01-08

Symptoms: Covid breakthrough infection. Symptoms included cough, headache, elevated heart rate.

Healthcare visit (other): I was only able to receive care after two weeks. My primary care was unable to see me and I could not go to my regular OB/gyn.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Unevaluable event	·	·	✓
SD	Breakthrough COVID-19	·	·	✓
SD	Cough	·	·	✓
SD	Headache	·	·	✓
SD	Heart rate increased	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release